Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Olutasidenib by Rigel Pharmaceuticals for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
Olutasidenib is under clinical development by Rigel Pharmaceuticals and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute Myeloblastic...
Olutasidenib by Rigel Pharmaceuticals for Myelodysplastic Syndrome: Likelihood of Approval
Olutasidenib is under clinical development by Rigel Pharmaceuticals and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase...
Fostamatinib disodium by Rigel Pharmaceuticals for Hidradenitis Suppurativa: Likelihood of Approval
Fostamatinib disodium is under clinical development by Rigel Pharmaceuticals and currently in Phase II for Hidradenitis Suppurativa. According to GlobalData,...